Jingzhong Ouyang

4PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 23, 2024
Adjuvant camrelizumab plus apatinib in resected hepatocellular carcinoma with microvascular invasion: a multi-center real world study.

Jingzhong Ouyang, Yi Yang, Yanzhao Zhou

|Jul 01, 2024
The Influence of Visceral Adiposity on Overall Survival: Exploring "Obesity Paradox" Among Hepatocellular Carcinoma Patients Who Receiving Immunotherapy.

Yanzhao Zhou, Jingzhong Ouyang, Hongcai Yang

|Sep 14, 2023
The MAPS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with targeted therapy plus immunotherapy.

Jingzhong Ouyang, Yi Yang, Yanzhao Zhou

|Sep 13, 2023
Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis.

Jingzhong Ouyang, Zhengzheng Wang, Kun Yuan

Pageof 1

Frequent Collaborators

3 joint publications

Yi Yang

3 joint publications

Qingjun Li

1 joint publications

Kun Yuan

1 joint publications

Hong Zhao